905 related articles for article (PubMed ID: 17985417)
21. Early treatment in early undifferentiated arthritis.
Olivieri I; Sarzi-Puttini P; Bugatti S; Atzeni F; d'Angelo S; Caporali R
Autoimmun Rev; 2012 Jun; 11(8):589-92. PubMed ID: 22037115
[TBL] [Abstract][Full Text] [Related]
22. Unresolved issues in identifying and overcoming inadequate response in rheumatoid arthritis: weighing the evidence.
Cohen SB; Cohen MD; Cush JJ; Fleischmann RM; Mease PJ; Schiff MH; Simon LS; Weaver AL
J Rheumatol Suppl; 2008 Feb; 81():4-30; quiz 31-4. PubMed ID: 19193621
[TBL] [Abstract][Full Text] [Related]
23. Early rheumatoid arthritis: strategies for prevention and management.
Combe B
Best Pract Res Clin Rheumatol; 2007 Feb; 21(1):27-42. PubMed ID: 17350542
[TBL] [Abstract][Full Text] [Related]
24. Optimizing treatment with biologics.
Mader R; Keystone E
J Rheumatol Suppl; 2007 Nov; 80():16-24. PubMed ID: 17985419
[TBL] [Abstract][Full Text] [Related]
25. Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: a decision tree for clinical practice based on rheumatologists' preferences.
Fautrel B; Guillemin F; Meyer O; de Bandt M; Berthelot JM; Flipo RM; Lioté F; Maillefert JF; Wendling D; Saraux A; Combe B; Le Loët X; ; ;
Arthritis Rheum; 2009 Apr; 61(4):425-34. PubMed ID: 19333993
[TBL] [Abstract][Full Text] [Related]
26. Timing the therapeutic window of opportunity in early rheumatoid arthritis: proposal for definitions of disease duration in clinical trials.
Raza K; Saber TP; Kvien TK; Tak PP; Gerlag DM
Ann Rheum Dis; 2012 Dec; 71(12):1921-3. PubMed ID: 22941769
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic approaches for early rheumatoid arthritis. How early? How aggressive?
Emery P
Br J Rheumatol; 1995 Nov; 34 Suppl 2():87-90. PubMed ID: 8535655
[TBL] [Abstract][Full Text] [Related]
28. [New therapeutic strategy of rheumatoid arthritis to reach the goal of suppression of joint destruction].
Yamaguchi Y; Yamamoto K
Clin Calcium; 2007 Apr; 17(4):463-73. PubMed ID: 17404474
[TBL] [Abstract][Full Text] [Related]
29. The evidence for early intervention.
Quinn MA; Cox S
Rheum Dis Clin North Am; 2005 Nov; 31(4):575-89. PubMed ID: 16287585
[TBL] [Abstract][Full Text] [Related]
30. Early inflammatory arthritis versus rheumatoid arthritis.
Finckh A
Curr Opin Rheumatol; 2009 Mar; 21(2):118-23. PubMed ID: 19339921
[TBL] [Abstract][Full Text] [Related]
31. Biologic therapy for early rheumatoid arthritis: the latest evidence.
Castro-Rueda H; Kavanaugh A
Curr Opin Rheumatol; 2008 May; 20(3):314-9. PubMed ID: 18388524
[TBL] [Abstract][Full Text] [Related]
32. Long-term outcomes of rheumatoid arthritis.
Sokka T
Curr Opin Rheumatol; 2009 May; 21(3):284-90. PubMed ID: 19342954
[TBL] [Abstract][Full Text] [Related]
33. Treatment of early rheumatoid arthritis in developing countries. Biologics or disease-modifying anti-rheumatic drugs?
Yen JH
Biomed Pharmacother; 2006 Dec; 60(10):688-92. PubMed ID: 17049202
[TBL] [Abstract][Full Text] [Related]
34. Evidence supporting the benefit of early intervention in rheumatoid arthritis.
Emery P
J Rheumatol Suppl; 2002 Nov; 66():3-8. PubMed ID: 12435162
[TBL] [Abstract][Full Text] [Related]
35. Patients with moderate rheumatoid arthritis (RA) achieve better disease activity states with etanercept treatment than patients with severe RA.
Keystone E; Freundlich B; Schiff M; Li J; Hooper M
J Rheumatol; 2009 Mar; 36(3):522-31. PubMed ID: 19228659
[TBL] [Abstract][Full Text] [Related]
36. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.
van Roon EN; van den Bemt PM; Jansen TL; Houtman NM; van de Laar MA; Brouwers JR
Clin Ther; 2009 Aug; 31(8):1737-46. PubMed ID: 19808132
[TBL] [Abstract][Full Text] [Related]
37. Early diagnosis of rheumatoid arthritis.
Visser H
Best Pract Res Clin Rheumatol; 2005 Feb; 19(1):55-72. PubMed ID: 15588971
[TBL] [Abstract][Full Text] [Related]
38. The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial.
Rantalaiho V; Korpela M; Hannonen P; Kautiainen H; Järvenpää S; Leirisalo-Repo M; Hakala M; Puolakka K; Julkunen H; Luosujärvi R; Möttönen T;
Arthritis Rheum; 2009 May; 60(5):1222-31. PubMed ID: 19404945
[TBL] [Abstract][Full Text] [Related]
39. Early rheumatoid arthritis.
Scott DL
Br Med Bull; 2007; 81-82():97-114. PubMed ID: 17540693
[TBL] [Abstract][Full Text] [Related]
40. Aspects of early arthritis. Traditional DMARD therapy: is it sufficient?
Machold KP; Nell VP; Stamm TA; Smolen JS
Arthritis Res Ther; 2006; 8(3):211. PubMed ID: 16719936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
